Tag
4 stories in this topic
A U.S. federal judge on Wednesday expressed skepticism regarding the accusations of roughly 69,000 individuals who assert that Johnson & Johnson’s baby powder and other talc-related products led to ovarian cancer. The judge stated that the plaintiffs must…
A California court has awarded $40 million to two women who claimed their ovarian cancer was a result of prolonged usage of Johnson & Johnson’s talcum-based baby powder. The Los Angeles Superior Court jury distributed the payout, allotting $18 million to…
LG Chem has partnered with U.S. bio company Cue Biopharma to develop immunotherapy drugs to treat cancer, the local company announced Monday. Immunotherapy drugs help patients fight diseases like cancer by enhancing their immune system. It is a relatively…
Yuhan Corporation announced on Monday that it has entered into a licensing agreement with Janssen Biotech, a subsidiary of Johnson & Johnson, to develop Lazertinib, a treatment for non-small cell lung cancer (Nsclc) that is undergoing clinical trials in…
Weekly Briefing
Tuesday, Thursday and a Saturday Weekly Wrap: the retail stories, numbers and moves that mattered across Asia. Nothing else, and you can unsubscribe in one click.
Read by retail operators, investors and brand teams across Asia.